Lifeward (LFWD) Non-Current Deffered Revenue (2014 - 2026)
Lifeward recorded quarterly Non-Current Deffered Revenue of $1.2 million in Q1 2026, down 2.03% quarter-over-quarter from $1.2 million in Q4 2025, and up 2.98% year-over-year from $1.2 million in Q1 2025.
Lifeward's Non-Current Deffered Revenue history runs 13 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue rose 2.98% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 2.98% YoY), while the FY2025 annual figure was $1.2 million, down 6.87% from the prior year.
- Non-Current Deffered Revenue came in at $1.2 million for Q1 2026 at Lifeward, down from $1.2 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.6 million in Q3 2023 to a low of $808000.0 in Q3 2022.
- A 5-year average of $1.1 million and a median of $1.2 million in 2026 frame the typical range for Non-Current Deffered Revenue.
- Across the five-year window, Non-Current Deffered Revenue soared 103.59% in 2023 and dropped 20.91% in 2024, its largest moves.
- Lifeward's Non-Current Deffered Revenue stood at $890000.0 in 2022, then jumped by 69.21% to $1.5 million in 2023, then retreated by 12.08% to $1.3 million in 2024, then dropped by 6.87% to $1.2 million in 2025, then slipped by 2.03% to $1.2 million in 2026.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $1.2 million, $1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | 895,000.00 |
| Dec 31, 2022 | 890,000.00 |
| Sep 30, 2022 | 808,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Mar 31, 2022 | 825,000.00 |
| Dec 31, 2021 | 866,000.00 |
| Sep 30, 2021 | 763,000.00 |
| Jun 30, 2021 | 727,000.00 |
| Mar 31, 2021 | 706,000.00 |
| Dec 31, 2020 | 667,000.00 |
| Sep 30, 2020 | 626,000.00 |
| Jun 30, 2020 | 594,000.00 |
| Mar 31, 2020 | 497,000.00 |
| Dec 31, 2019 | 521,000.00 |
| Sep 30, 2019 | 509,000.00 |
| Jun 30, 2019 | 489,000.00 |
| Mar 31, 2019 | 429,000.00 |
| Dec 31, 2018 | 431,000.00 |
| Sep 30, 2018 | 357,000.00 |
| Jun 30, 2018 | 325,000.00 |
| Mar 31, 2018 | 330,000.00 |
| Dec 31, 2017 | 262,000.00 |
| Sep 30, 2017 | 250,000.00 |
| Jun 30, 2017 | 283,000.00 |
| Mar 31, 2017 | 333,000.00 |
| Dec 31, 2016 | 284,000.00 |
| Sep 30, 2016 | 215,000.00 |
| Jun 30, 2016 | 225,000.00 |
| Mar 31, 2016 | 190,000.00 |
| Dec 31, 2015 | 171,000.00 |
| Dec 31, 2014 | 172,000.00 |